Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents

The ongoing severe acute respiratory syndrome pandemic caused by the novel coronavirus 2 (SARS-CoV-2) is associated with high morbidity and mortality rates, and it has created a pressing global need for effective antiviral therapies against it. COVID-19 disease pathogenesis is characterized by an in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelman, Ram, Bayatra, Areej, Kessler, Asa, Schwartz, Asaf, Ilan, Yaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473106/
https://www.ncbi.nlm.nih.gov/pubmed/32490731
http://dx.doi.org/10.1080/22221751.2020.1776161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473106/
https://www.ncbi.nlm.nih.gov/pubmed/32490731
http://dx.doi.org/10.1080/22221751.2020.1776161

Ejemplares similares